TCL Archive Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039. March 1, 2002
TCL Archive Pharmaceutical Industry: IVAX Official Broder Objects To Orphan Drug Policies of FDA May 9, 1997
TCL Archive NIH Budget Cut At $142 Million, NCI Could Get Small Increase Over 1981 Total; Schweiker Backs NIH Funds February 27, 1981
TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
TCL Archive Assembly of Scientists, started as a result of conflict of interest controversy, plans Sept. 14 meeting. September 9, 2005
TCL Archive Senate Committee Adds $100 Million for Cancer, Earmarks Extra Positions for NCI, Backs New Construction September 19, 1975
